凝血因子浓缩物对实验性失血性休克内皮细胞损伤标志物的影响
该研究纳入84只大鼠,建立压力控制(MAP 30-35 mm Hg)及实验室指标引导(乳酸>2.2 mmol/L、碱缺失>5.5 mmol/L)的失血性休克模型,分别用新鲜冰冻血浆(FFP)、人血白蛋白(HA)或乳酸林格液(RL)复苏,并在RL或HA基础上补充纤维蛋白原浓缩物(FC)或凝血酶原复合物浓缩物(PCC)。结果显示,FFP复苏对sVEGFR1无影响(FFP 19.3 ng/mL vs RL 15.9 ng/mL;RL+FC 19.7 ng/mL;RL+PCC 18.9 ng/mL;无统计学差异),观察终点时各组间syndecan-1相似,HA+FC组syndecan-1浓度最高(12.07 ng/mL)。FFP复苏使硫酸乙酰肝素恢复至基线水平(基线36 ng/mL vs 观察终点36 ng/mL)。作者认为,血浆复苏使循环硫酸乙酰肝素正常化但未影响syndecan-1,凝血因子浓缩物联合给药对糖萼脱落无额外作用,提示其缺乏治疗潜力。
要点
- 大鼠失血性休克模型中,FFP复苏使硫酸乙酰肝素恢复至基线(基线36 ng/mL vs 观察终点36 ng/mL)。
- FFP复苏对sVEGFR1无影响:FFP 19.3 ng/mL vs RL 15.9 ng/mL,RL+FC 19.7 ng/mL,RL+PCC 18.9 ng/mL,无统计学差异。
- 观察终点时各组syndecan-1相似,HA+FC组浓度最高(12.07 ng/mL)。
- 凝血因子浓缩物(FC或PCC)联合RL或HA对糖萼脱落无额外作用,作者认为缺乏治疗潜力。
适用人群与场景
- 84只大鼠,建立压力控制(MAP 30-35 mm Hg)及实验室指标引导(目标截断值:乳酸>2.2 mmol/L、碱缺失>5.5 mmol/L)的失血性休克模型。
诊断标准与关键阈值
- 失血性休克模型目标:MAP 30-35 mm Hg;实验室指标引导目标截断值:乳酸>2.2 mmol/L、碱缺失>5.5 mmol/L。
研究设计与关键结果
- 研究类型:实验性体内研究,84只大鼠。
- 干预:分别用新鲜冰冻血浆(FFP)、人血白蛋白(HA)或乳酸林格液(RL)复苏,并在RL或HA基础上补充纤维蛋白原浓缩物(FC)或凝血酶原复合物浓缩物(PCC)。
- 主要终点:FFP复苏对sVEGFR1无影响(FFP 19.3 ng/mL vs RL 15.9 ng/mL;RL+FC 19.7 ng/mL;RL+PCC 18.9 ng/mL;无统计学差异)。
- 观察终点时syndecan-1在各组间相似,HA+FC组浓度最高(12.07 ng/mL)。
- FFP复苏使硫酸乙酰肝素恢复至基线(基线36 ng/mL vs 观察终点36 ng/mL)。
证据类型、等级与局限
- 证据类型:实验性体内研究(大鼠)。
- 证据等级:V级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,血浆复苏使循环硫酸乙酰肝素正常化但未影响syndecan-1;凝血因子浓缩物联合给药对糖萼脱落无额外作用,提示其缺乏治疗潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Plasma-based resuscitation showed protective effects on the endothelial glycocalyx compared with crystalloid resuscitation. There is paucity of data regarding the effect of coagulation factor concentrates (CFC) on the glycocalyx in hemorrhagic shock (HS). We hypothesized that colloid-based resuscitation supplemented with CFCs offers a therapeutic value to treat endothelial damage following HS.
METHODS: Eighty-four rats were subjected to pressure-controlled (mean arterial pressure (MAP) 30-35 mm Hg) and lab-guided (targeted cutoff: lactate >2.2. mmol/L and base deficit > 5.5 mmol/L) HS. Animals were resuscitated with fresh frozen plasma (FFP), human albumin (HA) or Ringer's lactate (RL) and RL or HA supplemented with fibrinogen concentrate (FC) or prothrombin complex concentrate (PCC). Serum epinephrine and the following markers of endothelial damage were assessed at baseline and at the end-of-observation (120 min after shock was terminated): syndecan-1, heparan sulfate, and soluble vascular endothelial growth factor receptor 1 (sVEGFR 1).
RESULTS: Resuscitation with FFP had no effect on sVEGFR1 compared with crystalloid-based resuscitation (FFP: 19.3 ng/mL vs. RL: 15.9 ng/mL; RL+FC: 19.7 ng/mL; RL+PCC: 18.9 ng/mL; n.s.). At the end-of-observation, syndecan-1 was similar among all groups. Interestingly, HA+FC treated animals displayed the highest syndecan-1 concentration (12.07 ng/mL). Resuscitation with FFP restored heparan sulfate back to baseline (baseline: 36 ng/mL vs. end-of-observation: 36 ng/mL).
CONCLUSION: The current study revealed that plasma-based resuscitation normalized circulating heparan sulfate but not syndecan-1. Co-administration of CFC had no further effect on glycocalyx shedding suggesting a lack of its therapeutic potential.
LEVEL OF EVIDENCE: VExperimental in vivo study.
参考来源
- Hofmann N, Zipperle J, Brettner F, et al. Effect of Coagulation Factor Concentrates on Markers of Endothelial Cell Damage in Experimental Hemorrhagic Shock. Shock. 2019. PMID: 30407369. doi:10.1097/SHK.0000000000001286
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。